Zions Bancorporation’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-60
Closed -$1.42K 1028
2022
Q4
$1.42K Sell
60
-166
-73% -$4.48K ﹤0.01% 982
2022
Q3
$6K Buy
226
+49
+28% +$1.72K ﹤0.01% 763
2022
Q2
$6K Sell
177
-87
-33% -$3.69K ﹤0.01% 831
2022
Q1
$19K Sell
264
-37
-12% -$2.67K ﹤0.01% 685
2021
Q4
$28K Buy
301
+17
+6% +$2.03K ﹤0.01% 560
2021
Q3
$36K Buy
284
+241
+560% +$35.1K ﹤0.01% 497
2021
Q2
$7K Sell
43
-29
-40% -$4.7K ﹤0.01% 791
2021
Q1
$13K Sell
72
-22
-23% -$5.1K ﹤0.01% 652
2020
Q4
$19K Buy
94
+34
+57% +$6.91K ﹤0.01% 561
2020
Q3
$13K Hold
60
﹤0.01% 623
2020
Q2
$11K Buy
+60
New +$10.5K ﹤0.01% 616

Other funds holding TDOC

Zions Bancorporation's TDOC Position: Q1 2023 in Review

Zions Bancorporation sold out of Teladoc Health (TDOC) in Q1 2023, closing a stake of 60 shares — an estimated $1.42K sold.

Zions Bancorporation first reported a position in TDOC in Q2 2020 and held it in 11 quarters. The position peaked at $36K in Q3 2021. 429 funds tracked by Wall St. Rank hold TDOC as of Q1 2023.

  • Zions Bancorporation reported no remaining Teladoc Health position as of Q1 2023 after selling out during the quarter.
  • Zions Bancorporation sold 60 Teladoc Health shares in Q1 2023, an estimated $1.42K.
  • Zions Bancorporation first reported a position in Teladoc Health in Q2 2020 and held it in 11 quarters.
  • Zions Bancorporation's Teladoc Health position peaked at $36K in Q3 2021.
  • 429 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2023.

Based on Zions Bancorporation's 13F filing for Q1 2023, filed 10 May 2023.